Company Filing History:
2 out of 22 
2 out of 5,089 
2 out of 4 Years Active: 2010-2014
Title: **Damien Boeglin: Innovator in Ghrelin Research**
Introduction
Damien Boeglin, an accomplished inventor based in Eguisheim, France, has made significant strides in the field of medicinal chemistry. With two patents to his name, his work focuses on innovative treatments utilizing novel triazole derivatives as ligands for growth hormone secretagogue receptors, specifically targeting physiological and pathophysiological conditions.
Latest Patents
One of Boeglin's notable patents involves the design of triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors. This invention addresses a range of medical conditions in mammals, primarily focusing on human health. His work details antagonists and agonists for GHS receptors, which can lead to therapeutic advancements in treating conditions such as growth retardation, cachexia, energy balance regulation, obesity, diabetes, tumor cell proliferation, and postoperative complications. These findings are pivotal for enhancing patient care and therapeutic outcomes in various areas of medicine.
Career Highlights
Throughout his career, Damien Boeglin has worked with renowned institutions including Zentaris GmbH and the Centre National De La Recherche Scientifique. His roles in these organizations have contributed to his expertise in medicinal chemistry and his passion for developing innovative solutions aimed at improving health.
Collaborations
Boeglin has collaborated with distinguished professionals such as Daniel Perrissoud and Jean Martinez. These collaborations have fostered a productive environment for intellectual exchange and innovation, further amplifying the impact of his work in the scientific community.
Conclusion
Damien Boeglin stands out as an influential inventor in the realm of pharmacological research, particularly within the scope of growth hormone secretagogue receptors. His patents represent a significant advancement in medical treatment options, showcasing his dedication to improving human health through innovative scientific discoveries.